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EDITORIAL COMMENT
Is it Time to Offer Elective
Percutaneous Treatment
of the Unprotected
Left Main Coronary Artery?*
Donald S. Baim, MD, FACC
Boston, Massachusetts
As the techniques for catheter-based intervention continue
to be refined, up to 35% of patients who undergo diagnostic
catheterization are referred for such therapy, while only
roughly 25% are referred for bypass surgery. Much of this
growth in the use of catheter-based intervention has come
from the treatment of patients who previously received
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medical therapy (e.g., those with acute myocardial infarction
or mild angina with a positive functional study, etc.)
although some of the growth clearly has come from treating
patients once considered the exclusive province of bypass
surgery (e.g., those with anatomically-suitable multivessel
disease). One of the remaining bastions of surgical domi-
nance, however, has been patients who have “significant”
(.50% or certainly .70% diameter stenosis) narrowing of
the left main coronary trunk, as found in 7% to 10% of all
diagnostic catheterization procedures. This preference for
surgical revascularization is based on trials conducted in the
late 1970s, which demonstrated that surgery reduced (from
nearly 29% to 7%) the substantial three-year mortality seen
with medical therapy (1).
While early exploration of catheter-based intervention in
the left main showed that acute procedure success and
complications were not prohibitive (even sans hemodynamic
support techniques such as intraaortic balloon pumping or
cardio-pulmonary support), the subsequent clinical course
proved troublesome (2). In patients whose left main was
“unprotected”—that is lacking a patent graft to either the
left anterior descending or circumflex—the one-year mor-
tality after left main angioplasty was 30% and, hence, not
much better than that for medical therapy. In contrast,
patients who underwent angioplasty of a left main that was
“protected” by a patent graft (usually an internal mammary
graft to the left anterior descending so that the left main was
functionally a proximal circumflex vessel, fared much better
with a one-year mortality ,10%. In our center’s series of 46
left main lesions (42 protected), for example, the one-year
mortality was 2%, with a repeat target vessel revasculariza-
tion rate of 13%, approaching the results of treatment
elsewhere in the coronary tree (3). Part of the improved
results stems from the use of rotational atherectomy to
debulk calcification that may render such lesions difficult to
dilate, and stenting to stabilize any procedure-related dis-
section and resist the elastic recoil common with ostial
lesions). These advances have helped catheter-based inter-
ventions of protected left main lesions be recognized as an
excellent option to reoperation in anatomically suitable
patients and grow to comprise 1% to 2% of interventional
volume.
The issue in question, however, is whether interventional
techniques should be considered as an option for the
unprotected left main lesion. High-quality data on the
subject have been difficult to come by and frequently
anecdotal. In 1997, Ellis collected 107 such patients who
had undergone treatment at one of 16 international centers
between 1994 and 1996, representing only 0.2% of inter-
ventional procedures at those institutions (4). Procedural
and long-term outcome varied significantly with baseline
status, being substantially worse for patients who had acute
myocardial infarction or other factors (advanced age, left
ventricular dysfunction, renal or cerebrovascular disease)
that rendered them high-risk for operation. Despite stent
placement in only half of the cases, the technical success was
98.9%, with an in-hospital mortality of 12% for elective
patients (5.9% for those who were good surgical candidates
and 30% for those who were not). Cumulative one-year
mortality was 29% (16% in patients who were surgical
candidates and 70% in those who were not). Angiographic
restenosis was 22% at .4-month restudy but was possibly
underestimated because early deaths were not included as
restenotic events.
More recently, several single centers have published their
own series of catheter treatment of unprotected left main
lesions. Kosuga et al. (5) reported their results in 107
patients who underwent the procedure emergently (n 5 24)
or electively (n 5 83). The angiographic success rate was
generally high (96.4%), and the in-hospital mortality in the
elective group was low (3.6%), particularly compared with
the 35% to 40% mortality in nonelective patients. With
limited use of stents (14% of cases), the angiographic
restenosis rate in the elective patients was high (40%).
Through multiple repeat catheter-based interventions for its
treatment, however, the three-year mortality was 22.5% for
elective patients (5% in the 33 patients deemed to be low
risk for coronary artery bypass grafting (CABG and 30% in
patients deemed to be high risk for CABG).
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When stents are used routinely for left main intervention,
even better results may be obtained. Park et al. (6) reported
42 patients with normal left ventricular function who were
treated by stenting with a 100% success and no in-hospital
complications. One-year mortality was 2.5%, but seven
patients (17%) developed recurrences that presented with
unstable angina at a mean of two months, leading to bypass
in five of the patients and repeat catheter treatment in the
remaining two. Wong et al. (7) reported a series of purely
elective stent procedures in 55 patients (drawn from 66 with
that anatomy on diagnostic angiography). The procedural
success was 100%, with no major complications. Eleven
patients (20%) had symptomatic recurrence, which was
managed by CABG in seven patients and repeat interven-
tion in two patients, with only one late death (2%).
These data are reinforced by the findings of the current
paper by Silvestri et al. (8), which reports the results in 140
elective left main stent procedures, including 47 patients
deemed to be at high risk for CABG (age .75 years,
ejection fraction ,35%) and 93 patients deemed to be at
low risk for CABG. Procedure success was 100%, with a
30-day mortality of 6% (9% in the high risk and 0% in the
low risk patients). One-year target lesion revascularization
was 18% (three-quarters surgical), and one-year mortality
was 8% (11% in the high risk and 2.5% in the low risk
subsets) including noncardiac events. These results for
elective stenting both in patients deemed to be at low risk
for surgery (i.e., a 2% to 5% one-year mortality) and those
deemed to be at higher risk (i.e., a 10% one-year mortality)
for the first time approach those provided by the gold
standard of bypass surgery. Given the stability of stented
lesions after one year, these favorable results will most likely
be maintained over longer follow-up.
Before recommending broad application of catheter based
treatments for unprotected left main disease, however, it is
important to more fully address the two remaining chal-
lenges: first, we must develop a reliable way to deal with the
substantial number of lesions that involve the distal left
main bifurcation and extend into the left coronary branches,
which accounted for more than half of the cases in the
Silvestri series. Silvestri’s practice of finishing such proce-
dures with “kissing balloon” inflations extending into the
proximal left anterior descending and circumflex may help,
but is unlikely to suffice as a reliable treatment of true distal
left main bifurcation lesions. Debulking techniques (often
directional or rotational atherectomy followed by stenting)
appear to be helpful in such lesions, but were used infre-
quently (6% of cases) here. The development of newer-
generation stents that allow a variety of bifurcation stenting
approaches will be essential. Second, we must work on
better techniques for preventing, detecting and managing
left main restenosis—a problem that may present with late
sudden death in this unprotected population. The dictum of
“bigger is better,” so well established elsewhere in the
coronary tree (9), also applies to the left main, with much
lower clinical recurrence rates when a larger final lumen area
can be obtained (target lesion revascularization rates of
50% for ,7 mm2, 10% for 7–9 mm2, and 5% for final
CSA .9 mm2 [equivalent to ;3.5 mm in minimum
diameter] (10). It is important to recognize, however,
that none of our current techniques eliminates restenosis
and that we must aggressively monitor such patients if we
are to mitigate the potential lethality of restenosis in the
unprotected left main. One approach is the performance
of routine two to three month follow-up angiography to
detect aggressive restenosis (estimated incidence ;20%)
and then refer such patients to surgery, as has been done
in most of the series described above. Perhaps when
intracoronary brachytherapy techniques are approved by
the FDA (possibly as soon as mid 2000), radiation at the
time of initial treatment or during the treatment of the
first recurrence (11) may allow more definitive and
durable catheter-based treatment.
Speaking from the current perspective, however, most
patients with significant left main disease who are accept-
able candidates for bypass surgery should probably still
undergo that proven and effective therapy, particularly if the
left main lesion is just one part of complex multivessel
disease. One exception may be patients judged to be at
prohibitively high surgical risk and who are anatomically
suitable for catheter-based treatment. They may undergo
stenting with aggressive attempts to maximize the lumen
diameter (including prestent rotational atherectomy when-
ever calcium is present or expansion of the predilatation
balloon is impeded at moderate pressure). For anatomically
suitable patients who are at low risk for bypass surgery but
are averse to surgery and understand the risks and unproved
benefit of left main stenting, there may be some latitude to
allow selective use of catheter-based techniques by experi-
enced operators (perhaps under protocols sanctioned by the
local Institutional Review Boards). Such elective stenting of
left main patients deemed at low risk for bypass surgery
should, however, undergo the careful randomized evaluation
it deserves before becoming the “standard of care.” An
equivalence trial design assuming a one-year mortality of 8%
with surgery and a delta of 6% could be performed with as
few as 500 patients but showing equivalency to within a
smaller delta (e.g., 2% to 3%) would require an
impractically-large trial of several thousand patients. Until a
trial shows the substantial equivalence of left main stenting
to surgery in lower risk elective patients suitable for surgery,
acceptance of catheter-based left main intervention in such
patients based only on current anecdotal evidence would
(however encouraging) seem premature when the highly
effective surgical option is readily available.
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